COLUMN GROUP III-A, LP — SEC insider filings
SEC reporting owner CIK 1668085. 50 insider filings on record with FilingPulse; latest filed 2026-10-22.
Transaction summary — filings shown
Covers all 50 filings on record, filed 2020-08-17 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 105 legs across 41 filings — 55,052,166 shares, $119,858,853 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): 15 legs across 5 filings — 11,437,446 shares, $80,085,180 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 61.
- Largest priced transaction: sale of 1,075,133 shares @ $36.40 ($39,134,841) in Revolution Medicines, Inc., filed 2020-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | 10% owner | 1 | — | 2 legs · 2,027,156 sh · $73,788,478 | — |
| Tenaya Therapeutics, Inc. (TNYA) | 10% owner | 11 | 8 legs · 49,313,559 sh · $64,556,620 | 12 legs · 9,400,290 sh · $5,927,199 | 10 |
| NGM BIOPHARMACEUTICALS INC (NGM) | 10% owner | 27 | 72 legs · 3,899,822 sh · $31,317,626 | — | 14 |
| Surrozen, Inc./DE (SRZN) | 10% owner | 9 | 25 legs · 1,838,785 sh · $23,984,607 | — | 35 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) | 10% owner | 2 | — | 1 leg · 10,000 sh · $369,503 | 2 |
Insider filings — COLUMN GROUP III-A, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-22 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Option exercise/expiry (X): 485,830 @ $11.60 · Option exercise/expiry (X): 548,653 @ $11.60 · Option exercise/expiry (X): 517,241 @ $11.60 · Option exercise/expiry (X): 728,745 (derivative) · Option exercise/expiry (X): 822,980 (derivative) · Option exercise/expiry (X): 775,861 (derivative) · +3 more | EDGAR |
| 2026-02-26 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Sale (S): 309,228 @ $0.62 · Sale (S): 349,212 @ $0.62 · Sale (S): 1,649,281 @ $0.56 · Sale (S): 1,862,545 @ $0.56 | EDGAR |
| 2026-02-24 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Sale (S): 245,965 @ $0.61 · Sale (S): 277,769 @ $0.61 · Sale (S): 143,709 @ $0.60 · Sale (S): 162,291 @ $0.60 | EDGAR |
| 2026-02-12 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Sale (S): 161,422 @ $0.82 · Sale (S): 182,295 @ $0.82 · Sale (S): 1,905,115 @ $0.68 · Sale (S): 2,151,458 @ $0.68 | EDGAR |
| 2026-01-20 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Purchase (P): 5,590 @ $19.89 · Purchase (P): 6,303 @ $19.89 · Purchase (P): 1,204 @ $20 · Purchase (P): 1,358 @ $20 · Purchase (P): 8,484 @ $19.60 · Purchase (P): 9,568 @ $19.60 | EDGAR |
| 2026-01-15 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Purchase (P): 5,861 @ $19.80 · Purchase (P): 6,609 @ $19.80 · Purchase (P): 2,596 @ $19.99 · Purchase (P): 2,927 @ $19.99 | EDGAR |
| 2026-01-08 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Purchase (P): 7,097 @ $19.89 · Purchase (P): 8,003 @ $19.89 | EDGAR |
| 2025-12-08 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 2,475 @ $17.35 · Purchase (P): 14,503 @ $19.54 · Purchase (P): 2,791 @ $17.35 · Purchase (P): 16,381 @ $19.54 | EDGAR |
| 2025-11-17 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 148,150 @ $12.65 · Purchase (P): 167,307 @ $12.65 | EDGAR |
| 2025-03-28 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 323,886 @ $11.60 · Purchase (P): 365,769 @ $11.60 · Purchase (P): 344,827 @ $11.60 · Code (H): 90,897 (derivative) · Purchase (P): 90,897 (derivative) · Code (H): 102,651 (derivative) · +15 more | EDGAR |
| 2025-03-07 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 35,714,284 @ $0.70 · Purchase (P): 35,714,284 (derivative) · Purchase (P): 17,857,142 (derivative) | EDGAR |
| 2024-04-17 | 4/A | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP | Purchase (P): 90,897 @ $15.50 · Purchase (P): 102,651 @ $15.50 | EDGAR |
| 2024-04-08 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 more | EDGAR |
| 2024-04-08 | 4 | Surrozen, Inc./DE (SRZN) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP | Purchase (P): 90,897 @ $15.50 · Purchase (P): 102,651 @ $15.50 · Purchase (P): 90,897 (derivative) · Purchase (P): 102,651 (derivative) · Purchase (P): 98,870 (derivative) · Purchase (P): 111,656 (derivative) · +4 more | EDGAR |
| 2024-02-14 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 2,222,222 @ $4.50 | EDGAR |
| 2023-11-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 16,791 @ $0.71 · Purchase (P): 5,840 @ $0.62 | EDGAR |
| 2023-03-14 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 6,779 @ $2.60 | EDGAR |
| 2023-02-10 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 1,500,000 @ $2.60 | EDGAR |
| 2023-02-01 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 7,542 @ $5.00 · Purchase (P): 176,730 @ $5.00 | EDGAR |
| 2023-01-25 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 9,900 @ $5.00 | EDGAR |
| 2023-01-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 37,639 @ $5.00 · Purchase (P): 500 @ $5.00 | EDGAR |
| 2023-01-23 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 69,739 @ $2.50 | EDGAR |
| 2023-01-19 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 49,463 @ $2.49 · Purchase (P): 135,688 @ $2.52 | EDGAR |
| 2023-01-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 5,378 @ $4.95 | EDGAR |
| 2023-01-12 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 100,070 @ $4.84 · Purchase (P): 209,000 @ $4.76 | EDGAR |
| 2022-12-14 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 300 @ $4.98 | EDGAR |
| 2022-11-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 35,997 @ $5.00 · Purchase (P): 4,330 @ $5.00 | EDGAR |
| 2022-11-23 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC | Purchase (P): 9,615,384 @ $2.60 | EDGAR |
| 2022-11-07 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 104,090 @ $4.99 · Purchase (P): 35,058 @ $4.72 | EDGAR |
| 2022-10-31 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 76,877 @ $4.86 | EDGAR |
| 2022-10-27 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 51,046 @ $4.75 · Purchase (P): 72,774 @ $4.85 | EDGAR |
| 2022-06-13 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 951,684 @ $13.50 · Purchase (P): 32,477 @ $13.50 | EDGAR |
| 2022-06-06 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 33,071 @ $13.03 · Purchase (P): 1,129 @ $13.03 | EDGAR |
| 2022-06-02 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 59,766 @ $13.47 · Purchase (P): 2,040 @ $13.47 · Purchase (P): 88,964 @ $13.45 · Purchase (P): 3,036 @ $13.45 | EDGAR |
| 2022-05-31 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 19,534 @ $13.49 · Purchase (P): 667 @ $13.49 · Purchase (P): 2,621 @ $13.45 · Purchase (P): 89 @ $13.45 | EDGAR |
| 2022-05-26 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 17,240 @ $13.37 · Purchase (P): 588 @ $13.37 · Purchase (P): 41,863 @ $13.43 · Purchase (P): 1,429 @ $13.43 | EDGAR |
| 2022-05-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 19,984 @ $13.25 · Purchase (P): 682 @ $13.25 · Purchase (P): 18,406 @ $13.48 · Purchase (P): 628 @ $13.48 | EDGAR |
| 2022-05-19 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 86,110 @ $13.42 · Purchase (P): 2,939 @ $13.42 · Purchase (P): 60,583 @ $13.20 · Purchase (P): 2,067 @ $13.20 | EDGAR |
| 2022-05-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 125,096 · Purchase (P): 4,269 · Purchase (P): 32,072 @ $12.90 · Purchase (P): 1,094 @ $12.90 | EDGAR |
| 2022-05-13 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 77,866 @ $11.23 · Purchase (P): 2,657 @ $11.23 · Purchase (P): 2,564 @ $11.85 · Purchase (P): 88 @ $11.85 · Purchase (P): 79,945 @ $11.62 · Purchase (P): 2,728 @ $11.62 · +2 more | EDGAR |
| 2022-05-11 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 80,430 @ $10.79 · Purchase (P): 2,745 @ $10.79 · Purchase (P): 30,233 @ $11.36 · Purchase (P): 1,032 @ $11.36 | EDGAR |
| 2022-01-26 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC | Purchase (P): 241,750 · Purchase (P): 8,250 · Purchase (P): 579,910 · Purchase (P): 19,791 | EDGAR |
| 2021-08-04 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP | Conversion (C): 4,389,282 @ $0 · Conversion (C): 4,956,842 @ $0 · Conversion (C): 3,727,742 (derivative) · Conversion (C): 4,209,755 (derivative) · Conversion (C): 472,659 (derivative) · Conversion (C): 533,781 (derivative) · +2 more | EDGAR |
| 2021-02-19 | 4 | CONSTELLATION PHARMACEUTICALS INC (CNST) jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, COLUMN GROUP GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim | Sale (S): 10,000 @ $36.95 | EDGAR |
| 2020-12-16 | 4 | CONSTELLATION PHARMACEUTICALS INC (CNST) jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, COLUMN GROUP GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim | Option exercise/expiry (X): 30,107 @ $1.55 · Option exercise/expiry (X): 30,107 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | Revolution Medicines, Inc. (RVMD) jointly with COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, PONOI CAPITAL, LP, Ponoi Capital II, LP, Ponoi Management, LLC, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V | Sale (S): 952,023 @ $36.40 · Sale (S): 1,075,133 @ $36.40 | EDGAR |
| 2020-09-03 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, Svennilson Peter, GOEDDEL DAVID V | Purchase (P): 36,494 @ $17.64 · Purchase (P): 27,595 @ $17.67 | EDGAR |
| 2020-08-31 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter | Purchase (P): 36,359 @ $17.79 · Purchase (P): 26,135 @ $17.89 | EDGAR |
| 2020-08-25 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter | Purchase (P): 7,321 @ $17.97 · Purchase (P): 11,024 @ $17.96 · Purchase (P): 100 @ $18 | EDGAR |
| 2020-08-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter | Purchase (P): 19,895 @ $17.89 · Purchase (P): 37,993 @ $17.49 · Purchase (P): 6,425 @ $17.89 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1668085 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs